Pharmafile Logo

Dietary Management

- PMLiVE

MHRA approves Pharming’s Joenja as first drug for rare immune disease APDS

Up to 40 people in the UK are affected by activated phosphoinositide 3-kinase delta syndrome

- PMLiVE

Ipsen’s Kayfanda granted EC approval to treat cholestatic pruritus in Alagille syndrome

The rare genetic disorder affects approximately three in every 100,000 births globally

- PMLiVE

British Skin Foundation receives £10,000 donation from Circle Health Group

The healthcare provider’s previous donation is supporting research into early melanoma detection

- PMLiVE

A social imperative: pharma’s essential role in online medical accuracy

We have a real opportunity, and arguably a responsibility, to stem the flow of misinformation

- PMLiVE

Global Health Beat – Ireland

Join us for this episode of Global Health Beat, featuring Dr. Richard Bambury as he explores the unique opportunities for HCPs in Ireland, including home health and educational programs. Matt...

CMI Media Group

New Marketplace Assessment Report from CMI Media Group and Compas Offers Definitive Analysis of Today’s Pertinent Healthcare Marketing Trends and Opportunities

New Marketplace Assessment Report from CMI Media Group and Compas Offers Definitive Analysis of Today’s Pertinent Healthcare Marketing Trends and Opportunities

CMI Media Group

- PMLiVE

Teeing Off with the Masters: Lessons for Brands Inspired by Golf’s Biggest Event

Highly encouraged to read this in Jim Nantz voice Hello friends. Consider a brand. Picture an experience. The Masters, one of the world’s most esteemed sporting events. It’s a hole-in-one...

CMI Media Group

- PMLiVE

MedAll – The Future of HCP Engagement Report 2024

AI is today’s hottest topic – so we partnered with MedAll and asked 1,000 doctors and other healthcare professionals across the globe for their view on this game-changing technology. The...

CMI Media Group

- PMLiVE

Global Health Beat – Canada

On this episode of Global Health Beat, Amanda Preto, VP of Marketing, and Matt Durham, Director of Global Media, sit down with Nadine Lafond, President of Ogilvy Health Canada, and...

CMI Media Group

- PMLiVE

AstraZeneca’s Tagrisso approved by FDA to treat EGFR-mutated lung cancer

More than 200,000 people are diagnosed with lung cancer in the US every year

- PMLiVE

FDA grants rare paediatric disease designation to Enterprise’s cystic fibrosis candidate

The genetic disease is estimated to affect more than 100,000 people globally

- PMLiVE

UCB shares positive two-year results for Bimzelx in hidradenitis suppurativa

The inflammatory skin disease affects about 1% of the population in most studied countries

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links